EcoDrugPlus

Receptor Interacting Serine/threonine Kinase 1

Ensembl ID : ENSPSNG00000015681
Gene Symbol: RIPK1
3 Cross references
197 Possible Orthologues:

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSPSNG00000018324
Gene Symbol: RPTOR
3 Cross references
209 Possible Orthologues:

Renin

Ensembl ID : ENSPSNG00000000284
Gene Symbol: REN
1 Cross references
218 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSPSNG00000009662
Gene Symbol: RET
3 Cross references
204 Possible Orthologues:

Retinoic Acid Receptor Alpha

Ensembl ID : ENSPSNG00000010408
Gene Symbol: RARA
3 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSPSNG00000004020
Gene Symbol: RARB
3 Cross references
450 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSPSNG00000005237
Gene Symbol: RARG
3 Cross references
446 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSPSNG00000008516
Gene Symbol: RXRA
3 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSPSNG00000020305
Gene Symbol: RXRB
3 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSPSNG00000014831
Gene Symbol: RXRG
3 Cross references
273 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSPSNG00000000481
Gene Symbol: RPL11
3 Cross references
158 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSPSNG00000008188
Gene Symbol: RPL13
3 Cross references
264 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).